Hing C. Wong
Chief Executive Officer at HCW Biologics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: HCW Biologics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
HCW Biologics Inc. June 14, 202494.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jul 29, 2026 | HCW Biologics Inc. | Open-market purchase | +23,210 | $2.59 | $60,114 |
| May 22, 2026 | HCW Biologics Inc. | Open-market purchase | +113,879 | $1.41 | $160,569 |
| May 16, 2025 | HCW Biologics Inc. | Open-market purchase | +8,054 | $7.45 | $60,002 |
| May 8, 2025 | HCW Biologics Inc. | Open-market purchase | +92,500 | $26.00 | $2,405,000 |
| Feb 20, 2024 | HCW Biologics Inc. | Grant or award | +739,288 | $1.40 | $1,035,003 |
| Sep 14, 2023 | HCW Biologics Inc. | Open-market purchase | +1,800 | $2.08 | $3,744 |
| Jun 2, 2023 | HCW Biologics Inc. | Open-market purchase | +800 | $1.54 | $1,232 |
| Jun 1, 2023 | HCW Biologics Inc. | Open-market purchase | +800 | $1.62 | $1,296 |
| May 31, 2023 | HCW Biologics Inc. | Open-market purchase | +2,000 | $1.55 | $3,100 |
| May 30, 2023 | HCW Biologics Inc. | Open-market purchase | +3,000 | $1.55 | $4,650 |
Questions about Hing C. Wong
What boards is Hing C. Wong on?
Hing C. Wong sits on the board of HCW Biologics Inc.
What company is Hing C. Wong the CEO of?
Hing C. Wong is Chief Executive Officer of HCW Biologics Inc.
How long has Hing C. Wong served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.